Seventy-three adult female cynomolgus monkeys fed an atherogenic diet were studied to determine the effect of two different combination contraceptive steroid preparations containing equivalent amounts of estrogen but different progestln components on plasma NpkJs and lipoproteins. Our hypothesis was that any high density llpoproteln (HDL) lowering effect of the contraceptive steroid preparations was proportional to the rise In total serum cholesterol caused by the progestins. O ral contraceptives usually contain a synthetic estrogen (i.e., ethinyl estradiol) and one of several synthetic progestins. Since estrogen and progestins each affect lipoprotein metabolism in unique ways, combined therapy can result in a variety of plasma lipoprotein changes that depend on the relative amounts and kinds of the two steroids. Most estrogens increase plasma high density lipoprotein (HDL) concentrations, while most combination oral contraceptives cause a decrease in plasma HDL due to the progestin component. 1 -2 Many oral contraceptives increase plasma low density lipoprotein (LDL)
O ral contraceptives usually contain a synthetic estrogen (i.e., ethinyl estradiol) and one of several synthetic progestins. Since estrogen and progestins each affect lipoprotein metabolism in unique ways, combined therapy can result in a variety of plasma lipoprotein changes that depend on the relative amounts and kinds of the two steroids. Most estrogens increase plasma high density lipoprotein (HDL) concentrations, while most combination oral contraceptives cause a decrease in plasma HDL due to the progestin component. 1 -2 Many oral contraceptives increase plasma low density lipoprotein (LDL) concentrations. 3 In particular, an increase in the concentration of small, dense LDL particles has been reported, whereas larger, less dense LDL particles may actually decrease in concentration. 4 There has been concern about these effects of oral contraceptives on lipoprotein metabolism because the changes are in the direction of a possible increased risk of coronary heart disease.
For ail our studies on contraceptive steroids, we have chosen to study female cynomolgus monkeys (Macaca fascicularis) because, like women, these animals respond to oral contraceptive treatment with marked increases in plasma triglyceride (TG) concentrations and decreases in plasma HDL concentrations, particularly the HDL 2 subtraction. 567 Since an inverse relationship between total serum cholesterol (TSC) and HDL cholesterol (HDL-C) exists for hypercholesterolemic monkeys (TSC>200 mg/ dl), 8 we were interested in exploring the interrelationship between TSC and HDL-C in monkeys given progestins of differing structures and pharmacological effects with an equivalent amount of estrogen. We hypothesized that any HDL-lowering effect of the contraceptive steroid preparations would be, as seen with dietary hypercholesterolemia, proportional to the rise in TSC caused by the progestins. In the experiment reported here, the effects of a norgestrel/ethinyl estradiol containing oral contraceptive on plasma lipoproteins of female monkeys were compared with those of a preparation containing ethynodiol diacetate/ethinyl estradiol. These female monkeys were fed a moderately atherogenic diet for 31 months during which oral contraceptive treatment was given for 2 years.
Methods Animals
Seventy-three adult female cynomolgus macaques (Macaca fascicularis) were used for the study. The animals were fed for 31 months a moderately atherogenic diet, supplied by Bioserve Inc. (Frenchtown, NJ), that contained 0.39 mg cholesterol/kcal and 38% of calories as saturated fat (lard).
Experimental Design
The study was divided into two periods: a 7-month baseline and a 24-month experimental period. During the baseline period, the animals consumed the atherogenic diet, and blood samples were taken for TSC and HDL-C determinations. Using a stratified randomization technique, the animals were assigned to either the control group or to one of two treatment groups based on body weight, TSC, HDL-C, and menstrual cycle history. After assignment of all animals into one of the three groups, the mean and variance of TSC, HDL-C, body weight, and number of menstrual cycles of each of the three groups were essentially the same (Table 1) The contraceptive steroid pills were ground with a mortar and pestle and incorporated into the ground diet with a mixer. The laboratory prepared diets were kept frozen until time for feeding. Oral contraceptive dosages for these animals were equivalent, on a caloric intake basis, to human females consuming 1800 kcal and 1 oral contraceptive pill per day. The control group received no contraceptive steroids.
Llpld and Llpoproteln Quantltatlon
At 2-month intervals throughout the baseline and experimental periods, blood samples were taken from all animals to quantitate TSC, HDL-C, and serum TG concentrations. TSC and TG concentrations were determined by an autoanalyzer method using LJpid Research Clinic methodology. 9 HDL-C concentrations were quantitated after precipitation of apoprotein (apo) B containing lipoprotein from serum with heparin-manganese.
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Low Density Llpoproteln Molecular Weight Determination LDL molecular weight measurements were made for all animals during the baseline period (5 months after diet initiation; 2 months before treatment started) and after 24 months of oral contraceptive treatment. Blood samples were obtained from the femoral vein of fasted animals after intramuscular administration of ketamine (10 mg/kg). Blood was collected in tubes containing 0.1% EDTA, 0.02% NaN 3 , 0.04% DTNB, pH 7.4 (final concentration), and this was immediately placed on ice. Plasma was harvested by low speed centrifugation at 4°C. The lipoproteins were isolated from plasma by uttracentrifugation and agarose column chromatography. 11 With this procedure, LDL size (i.e., LDL molecular weight) was determined for each sample by including a trace amount of an iodinated LDL preparation of known molecular weight.
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Gradient Gel Electrophoresls
Prepoured polyacrylamide gradient gels (4% to 30%; Pharmacia, Piscataway, NJ) were used to investigate HDL subfraction size heterogeneity. Gels were run as described previously. 12 Briefly, d<1.225 g/ml lipoproteins (four parts) were mixed with one part of a solution consisting of 40% sucrose and 0.01% bromphenol blue, and a 10 to 20 /xl aliquot containing 10 fig protein was applied to the gels. Gels were subjected to electrophoresis for 24 hours at 125 volts (10°C). After electrophoresls, gels were stained with Coomassie blue G-250 and were destained in 5% acetic acid. After destalning, the gels were scanned using a laser densitometer, and the percentage HDL subfraction protein distribution was calculated from the area units. Calculation of HDL particle size was based on the mobility of protein standards of known Stokes' diameters.
Statistics
All values are reported as means±standard error. Statistical comparisons were made between control and treatment groups by using analysis of variance and Fisher's least significant difference test. A paired f test was used for comparisons before and after treatment within a single group. Table 1 contains the TSC, HDL-C, and TG concentrations and the LDL molecular weight values for the three groups of animals during the baseline period (5 months after diet initiation) and after 21 to 23 months of treatment. There was no significant difference in any lipid or lipoprotein measurements among groups during the baseline period. As expected, the lipid and lipoprotein measurements for the control group were similar after the 24-month experimental period compared with the pre-experimental (baseline) values.
Results
The Ovral treatment group had a significant increase in plasma TG (p<0.01) and a significant decrease in HDL-C (p=0.01) after treatment compared with baseline values. LDL molecular weight and TSC after Ovral treatment were not significantly different compared with pretreatment values. After 21 to 23 months of treatment, the Ovral group had 50% less HDL-C compared with the controls. TSC, TG, and LDL molecular weight were not significantly different between the Ovral and control group after the treatment period.
The Demulen group responded in a manner that was qualitatively similar to that of the Ovral group. After 21 to 23 months of Demulen treatment, TG were significantly increased, and HDL-C and LDL molecular weight were significantly decreased compared with the preexperimental values (Table 1) . Compared with the control group at 21 to 23 months of treatment, the Demulen group had significantly higher TSC and TG concentrations and significantly lower HDL-C concentrations and smaller LDL. After 21 to 23 months of treatment, the only significant difference between the Ovral versus Demulen groups was high TG concentrations for the Demulen group.
Next, the interrelationship between TSC, TG, and HDL-C concentrations for the three groups of animals were examined. To do this, the average bimonthly TSC or TG values for each group taken throughout the baseline and experimental periods were plotted with the corresponding HDL-C value as shown in Figure 1 . Note that each point in Figure 1 represents the mean of 23 to 26 animals in its respective group. There was an inverse relationship between TSC and HDL-C concentrations: as TSC increased, HDL-C decreased. Interestingly, the control and Demulen values appeared to fall on the same regression line, while the Ovral values were uniformly lower. At any given TSC concentration from 375 to -500 mg/dl, the Ovral group had significantly (p<0.01) lower HDL-C concentrations compared with the control and Demulen groups (32±1, 50±1, and 43±1 mg/dl HDL-C, respectively). A similar relationship was found when plasma TG concentrations were plotted with HDL-C, that is, an inverse relationship was found between TG and HDL-C. The Ovral group had lower HDL-C concentrations at any given TG concentration compared with the control and Demulen groups.
To examine the effect of oral contraceptive treatment on HDL subfraction size distribution, gradient gel electrophoresls was used to further subfractionate HDL. The frequency of occurrence of different HDL size populations for the three groups was examined first. These data are shown in Figure 2 Using the nomenclature of Blanche et al. 12 and the subfraction size ranges established for a human population, we quantitated the percentage protein distribution of HDL subtractions for the three groups of animals by using laser densitometry. The demarcations of each subfraction size range are shown in Figure 2 . Table 2 summarizes the data from these analyses. HDL protein was approximately equally distributed among all four HDL subclasses for the control animals. Both contraceptive steroid treatments At total serum cholesterol concentrations >375 mg/dl, the average high density lipoprotein cholesterol (HDL-C) concentrations were 50±1,32+1, and 43±1 for the control, Ovral, and Demulen groups, respectively.
were associated with a statistically significant decrease in the percentage of (HDLa)^, protein (largest subtractions) and a corresponding increase in (HOLa^ggt protein (smallest subtractions). However, the difference in (HDLa,),,, distribution was not statistically significant between the two oral contraceptive treatment groups. HDL subtractions of intermediate size [(HDLjJgg, and (HDU^gJ were similar for control, Ovral, and Demulen groups.
To examine the effect of total HDL concentrations on the HDL subtraction distribution among the three groups, we plotted HDL-C (a measure reflective of total HDL) versus the percentage HDL subtraction protein distribution. The results are shown in Figure 3 . There was an increase in the percentage of (HDLa,),,,, protein with increasing HDL-C concentrations. Note that many of the Ovral-treated animals had values along the abscissa, indicating that they had no detectable (HDLa),^,. The percentage (HDLa,^),^ protein showed a marked decrease as HDL-C increased.
Oral contraceptive treatment was associated with an increase in plasma TG and a decrease in LDL size (Table 1 ). Since we had previously found an inverse relationship between LDL size and plasma TG concentrations, 13 a plot of the individual values of these variables for the three groups of animals was made ( Figure  4 ). There was no apparent relationship between LDL size and plasma TG concentrations over the range of values found in this study.
Discussion
This study was undertaken to determine the effect of two oral contraceptive formulations with the same dose and kind of estrogen but with different progestins on the plasma lipid and lipoprotein concentrations and HDL subtraction distribution of female cynomolgus monkeys. This animal model was chosen because we had previously shown that this species is suitable for studies on the effect of contraceptive steroids on plasma lipoproteins and atherosclerosis. 587 Both contraceptive formulations contained equivalent amounts of ethinyt estradiol (7.5 HQ daily) but different progestins; the Demulen group received 150 ng of ethynodiol diacetate daily while the Ovral group received 75 fug of norgestrel daily. The two oral contraceptive groups, on average, had higher TSC and TG concentrations but lower HDL cholesterol concentrations and smaller LDL compared with the control group. The (HDLa),,. subtraction protein was markedly reduced and the (HDLa^),,,, was increased for the oral contraceptive groups. Similar findings in women taking combination oral contraceptives 3414 - 18 and in cynomolgus monkeys given Ovral 19 have been reported. In the latter study, Ovral treatment resulted in a significant reduction of HDLj concentrations (measured by analytical ultracentrifugatJon) and LDL size compared with the female control group; total plasma cholesterol concentrations were not significantly different between the two groups. 19 The present study extends our initial findings to investigate the interrelationships between plasma lipids and lipoproteins when two oral contraceptive formulations containing different progestins are used and to test our hypothesis that the HDL lowering effect of the two oral contraceptive preparations was proportional to the increase in TSC caused by the progestins. Despite the HDL lowering induced by both oral contraceptives, coronary artery atherosclerosis was not exacerbated and was reduced among Histogram of high density lipoprotein (HDL) subfraction size for female cynomolgus monkeys treated with oral contraceptives. d<1.225 g/ml lipoproteins from each animal were separated on 4% to 30% polyacrylamide gradient gels, and stained gels were scanned with a laser densitometer. Peak R f values for each HDL subfraction relative to albumin were plotted for each animal. The particle diameter scale was generated by using molecular weight standards of known Stokes' diameters. 12 Vertical dashed lines indicate the HDL subfraction size ranges reported for a human population.
12 the monkeys at highest risk on the basis of their lipid profile (unpublished data).
Perhaps the most striking effect of oral contraceptive treatment was its effect on HDL concentrations and subfraction distribution. In general, when nonhuman primates become hypercholesterolemic by consuming dietary cholesterol and saturated fat, there is a decrease in HDL concentrations and a redistribution of HDL subfraction mass; larger, less dense HDL 2b subtractions decrease in an amount relative to the smaller, more dense HDL 3 subtractions. 8 The same trend appears to occur for the control and Demulen groups; as TSC increased there was a proportional decrease in HDL-C (Figure 1 A) . In addition, as HDL-C decreased, the proportion of (HDL 2b ) gge particles in the (HDLaJgge size range for the Ovral group (Figure 2) . Thus, even though Demulen treatment resulted in a higher average degree of hypercnolesterolemia than Ovral treatment, the HDL cholesterol concentrations were 26% lower for the latter group when TSC concentrations were greater than 375 mg/dl (Figure 1 ). These results suggest: 1) that for an equivalent degree of hypercholesterolemia, Ovral treatment results in additional HDL lowering compared with that of dietary cholesterol alone or dietary cholesterol with a different progestin (i.e., ethynodiol diacetate), and 2) that this lowering occurs in the HDLa, size range ( Table 2 ). The decrease in HDL concentrations wtth Ovral treatment may be secondary to an increased catabolism of apo A-1 as suggested for anabolic steroid therapy 20 or may result from a decreased production of HDL precursor particles by the liver.
Progestjns alone given to women have reportedly decreased plasma concentrations of TG and HDL 2 and increased hepatic lipase activity, while estrogenic agents have the opposite effect. When combination contraceptive steroids are given, the plasma lipoprotein response depends on the dosage and biological effects of the progestin and the dosage of the estrogen component. 1 141818 and no change in HDL-C concentrations. 314 Many of the same responses were seen in the Ovral and Demulen treated animals of this study. It has been suggested that the decrease in HDL 2 concentrations accompanying progestin administration is related to an increase in hepatic lipase activity. 1 However, in studies of a subset of our animals, hepatic TG lipase was reduced 20% to 35% with oral contraceptive treatment compared with controls, but lipoprotein lipase activity was similar for all three groups. 21 Thus, the ethinyl estradiol component of these two contraceptive formulations appeared to have a predominant effect on plasma TG concentrations and hepatic lipase activity. However, HDL concentrations and subtraction distribution appear to be influenced more by the progestin by mechanisms that presumably include synthesis and catabolism of HDL or other intravascular metabolic events that modify HDL (i.e., lecithin:cholesterol acyttransferase) and not by hepatic lipase activity.
LDL size measured as LDL molecular weight was significantly smaller for the Demulen-treated group compared with control animals. LDL molecular weight is a strong positive predictor of the extent and severity of coronary artery atherosclerosis in nonhuman primates. 22 Diet-induced hypercholesterolemia in male cynomolgus monkeys is associated with an increase in LDL size, but for female cynomolgus monkeys it is associated with an increase in the number, not size, of LDL particles in plasma. 23 However, factors that control LDL particle size are poorly understood. One hypothetical mechanism involves TG for cholesteryl ester (CE) exchange. In this scheme, as plasma TG concentrations increase, there is TG for LDL CE exchange. Subsequent hydrolysis of the exchanged TG results in a reduction of LDL size. If this proposed mechanism were responsible for the smaller LDL of the Demulen group, which had higher TG concentrations, then an inverse relationship between LDL size and plasma TG concentrations would be expected. However, such a relationship was not apparent over the range of plasma TG values in this study (Figure 4 ). This is in contrast to hypertriglyceridemic humans 13 and to ethanolinduced hypertriglyceridemic monkeys (reference 24 and LL Rudel, personal communication), both of which demonstrated an inverse relationship between LDL size and plasma TG concentrations. Therefore, oral contraceptive treatment apparently affects LDL size by different mechanisms. In at least one other species of nonhuman primates, the African green monkey, a strong correlation between LDL size and hepatic CE content, as well as hepatic very low density lipoprotein cholesterol secretion, has been found (JS Parks, FL Johnson, and LL Rudel, unpublished observations). Whether such a relationship exists in the animals of this study is unknown.
